PMID,Title,Journal,Year
40494789,"[Prevalence of non-alcoholic fatty liver disease and related factors in people living with HIV in Taizhou, Zhejiang Province].",Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,2025
38734689,Angiolipoma associated with antiretroviral switch therapy: a case report.,AIDS research and therapy,2024
37995809,Genetic polymorphisms of CYP2B6 is a risk of metabolic associated fatty liver disease in Chinese population.,Toxicology and applied pharmacology,2023
37681155,Identification of potential molecular mechanisms and therapeutic targets for recurrent pelvic organ prolapse.,Heliyon,2023
36309141,Zinc normalizes hepatic lipid handling via modulation of ADA/XO/UA pathway and caspase 3 signaling in highly active antiretroviral therapy-treated Wistar rats.,Chemico-biological interactions,2022
34359857,NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved.,Cells,2021
31993314,Impact of obese levels on the hepatic expression of nuclear receptors and drug-metabolizing enzymes in adult and offspring mice.,Acta pharmaceutica Sinica. B,2020
28903510,Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,2017
